LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD
Market Cap: 45.8m USD

LAVA Therapeutics NV
Other Non-Cash Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

LAVA Therapeutics NV
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Other Non-Cash Items
$730k
CAGR 3-Years
-48%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Other Non-Cash Items
$23.6m
CAGR 3-Years
N/A
CAGR 5-Years
4%
CAGR 10-Years
28%
ProQR Therapeutics NV
NASDAQ:PRQR
Other Non-Cash Items
€438k
CAGR 3-Years
-60%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Other Non-Cash Items
$22.5m
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
-1%
argenx SE
XBRU:ARGX
Other Non-Cash Items
$239.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Other Non-Cash Items
$100.8m
CAGR 3-Years
N/A
CAGR 5-Years
47%
CAGR 10-Years
69%
No Stocks Found

LAVA Therapeutics NV
Glance View

Market Cap
45.8m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
2.52 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is LAVA Therapeutics NV's Other Non-Cash Items?
Other Non-Cash Items
730k USD

Based on the financial report for Dec 31, 2024, LAVA Therapeutics NV's Other Non-Cash Items amounts to 730k USD.

What is LAVA Therapeutics NV's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
31%

Over the last year, the Other Non-Cash Items growth was -85%. The average annual Other Non-Cash Items growth rates for LAVA Therapeutics NV have been -48% over the past three years , 31% over the past five years .

Back to Top